A putative white adipose tissue specific nuclear orphan receptor that interacts with the cAMP-response element of the human β3-adrenergic receptor gene

Molecular and Cellular Endocrinology

Volumn 165, Issue 1-2, 2000, Pages 85-95

  Kutoh, Eiji ^a   Ongenae, Nicolas ^a   Claeskens, An ^a   Verheyen, Willy ^a   Cheyns, Paul ^b   Neefs, Jean Marc ^c   Kaijen, Paul ^a  

^a Div Endocrinol Metab Janssen R   (Belgium)

^b Department of Surgery   (Belgium)

^c JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

3 adrenergic receptor; cAMP response element; Diabetes; Nuclear orphan receptor; Obesity; White adipose tissue (WAT)

Indexed keywords

ANTIDIABETIC AGENT; ANTIOBESITY AGENT; BETA 3 ADRENERGIC RECEPTOR; CELL NUCLEUS RECEPTOR; CYCLIC AMP; UNCLASSIFIED DRUG; WHITE ADIPOSE TISSUE SPECIFIC FACTOR 1;

ADIPOCYTE; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; COMPUTER ANALYSIS; CYCLIC AMP RESPONSIVE ELEMENT; DIABETOGENESIS; DNA BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN INTERACTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; WHITE ADIPOSE TISSUE;

3T3 CELLS; ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA; DNA PRIMERS; HUMANS; MICE; OBESITY; PHOSPHORYLATION; RECEPTOR CROSS-TALK; RECEPTORS, ADRENERGIC, BETA-3; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION, GENETIC;

EID: 0034713740     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(00)00262-8     Document Type: Article

References (48)

1. Alksnis M., Barkhem T., Stromstedt P.E., Ahola H., Kutoh E., Gustafsson J.A., Poellinger L., Nilsson S. High level expression of functional full length and truncated glucocorticoid receptor in Chinese hamster ovary cells. Demonstration of ligand-induced down-regulation of expressed receptor mRNA and protein. J. Biol. Chem. 266:1991;10078-10085.
2. Arch J.R., Wilson S. Prospects for beta 3-adrenoceptor agonists in the treatment of obesity and diabetes. Int. J. Obes. Relat. Metab. Disord. 20:1996;191-199.
3. Aumais J.P., Lee H.S., DeGannes C., Horsford J., White J.H. Function of directly repeated half-sites as response elements for steroid hormone receptors. J. Biol. Chem. 271:1996;12568-12577.
4. Austin S., Medvedev A., Yan Z.H., Adachi H., Hirose T., Jetten A.M. Induction of the nuclear orphan receptor RORgamma during adipocyte differentiation of D1 and 3T3-L1 cells. Cell Growth Differ. 9:1998;267-276.
5. Blumberg B., Evans R.M. Orphan nuclear receptors - new ligands and new possibilities. Genes Dev. 12:1998;3149-3155.
6. Carter M.E., Gulick T., Moore D.D., Kelly D.P. A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs. Mol. Cell. Biol. 14:1994;4360-4372.
7. Chawla A., Lazar M.A. Induction of Rev-ErbA alpha, an orphan receptor encoded on the opposite strand of the alpha-thyroid hormone receptor gene, during adipocyte differentiation. J. Biol. Chem. 268:1993;16265-16269.
8. Daniel S., Zhang S., DePaoli-Roach A.A., Kim K.H. Dephosphorylation of Sp1 by protein phosphatase 1 is involved in the glucose-mediated activation of the acetyl-CoA carboxylase gene. J. Biol. Chem. 271:1996;14692-14697.
9. Desclozeaux M., Poulat F., de Santa B., Capony J.P. et al. Phosphorylation of an N-terminal motif enhances DNA-binding activity of the human SRY protein. J. Biol. Chem. 273:1998;7988-7995.
10. Diamond M.I., Miner J.N., Yoshinaga S.K., Yamamoto K.R. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science. 249:1990;1266-1272.
11. Disch D.L., Rader T.A., Cresci S. et al. Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression. Mol. Cell. Biol. 16:1996;4043-4051.
12. Edwards D.P. Coregulatory proteins in nuclear hormone receptor action. Vitam. Horm. 55:1999;165-218.
13. Enmark E., Gustafsson J.A. Orphan nuclear receptors - the first eight years. Mol. Endocrinol. 10:1996;1293-1307.
14. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
15. Freedman L.P., Luisi B.F. On the mechanism of DNA binding by nuclear hormone receptors: a structural and functional perspective. J. Cell. Biochem. 51:1993;140-150.
16. Forman B.M., Chen J., Blumberg B. et al. Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol. Endocrinol. 8:1994;1253-1261.
17. Forman B.M., Evans R.M. Nuclear hormone receptors activate direct, inverted, and everted repeats. Ann. New York Acad. Sci. 761:1995;29-37.
18. Giacobino J.P. Beta 3-adrenoceptor: an update. Eur. J. Endocrinol. 132:1995;377-385.
19. Gottlicher M., Heck S., Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76:1998;480-489.
20. Hirose T., Kurebayashi S. Adipocyte differentiation and nuclear receptor. Nippon Rinsho. 55:1997;1596-1604.
21. Keller H., Dreyer C., Medin J., Mahfoudi A., Ozato K., Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA. 90:1993;2160-2164.
22. Kutoh E., Margot J.B., Schwander J. Genomic structure and regulation of the promoter of the rat insulin-like growth factor binding protein-2 gene. Mol. Endocrinol. 7:1993;1205-1216.
23. 3-adrenoceptor gene. Endocrine. 5:1996;265-274.
24. Leggett R.W., Armstrong S.A., Barry D., Mueller C.R. Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. J. Biol. Chem. 270:1995;25879-25884.
25. Liggett S.B., Schwinn D.A. Multiple potential regulatory elements in the 5′ flanking region of the beta 3-adrenergic receptor. DNA Seq. 2:1991;61-63.
26. Lin F.T., Lane M.D. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. Proc. Natl. Acad. Sci. USA. 91:1994;8757-8761.
27. Luckow B., Schutz G. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 15:1987;5490.
28. Mandrup S., Lane M.D. Regulating adipogenesis. J. Biol. Chem. 272:1997;5367-5370.
29. Mandrup S., Loftus T.M., MacDougald O.A., Kuhajda F.P., Lane M.D. Obese gene expression at in vivo levels by fat pads derived from s.c. implanted 3T3-F442A preadipocytes. Proc. Natl. Acad. Sci. USA. 94:1997;4300-4305.
30. Mangelsdorf D.J., Thummel C., Beato M. et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
31. Meyer T.E., Habener J.F. Cyclic adenosine 3′,5′-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid- binding proteins. Endocr. Rev. 14:1993;269-290.
32. Monia Y.T., Peleg S., Gagel R.F., Monia Y.T. Cell type-specific regulation of transcription by cyclic adenosine 3′,5′-monophosphate-responsive elements within the calcitonin promoter. Mol. Endocrinol. 9:1995;784-793.
33. Mukherjee R., Jow L., Croston G.E., Paterniti J.R.J. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J. Biol. Chem. 272:1997;8071-8076.
34. O'Malley B.W., Conneely O.M. Orphan receptors: in search of a unifying hypothesis for activation. Mol. Endocrinol. 6:1992;1359-1361.
35. Polak M. New data on nuclear hormone receptor cofactors suggest a control of transcriptional repression by hormone-dependent chromatin remodelling. Eur. J. Endocrinol. 137:1997;455-456.
36. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press.
37. Sap J., Munoz A., Schmitt J., Stunnenberg H., Vennstrom B. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product. Nature. 340:1989;242-244.
38. Schreiber E., Matthias P., Muller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
39. Seed B., Sheen J.Y. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene. 67:1988;271-277.
40. Strosberg A.D. Structure and function of the beta 3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol. 37:1997;421-450.
41. Southern P.J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:1982;327-341.
42. Smas C.M., Sul H.S. Control of adipocyte differentiation. Biochem. J. 309 (Pt 3):1995;697-710.
43. Spiegelman B.M. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes. 47:1998;507-514.
44. Thomas R.F., Holt B.D., Schwinn D.A., Liggett S.B. Long-term agonist exposure induces upregulation of beta 3-adrenergic receptor expression via multiple cAMP response elements. Proc. Natl. Acad. Sci. USA. 89:1992;4490-4494.
45. van Spronsen A., Nahmias C., Krief S., Briend-Sutren M.M., Strosberg A.D., Emorine L.J. The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes. Eur. J. Biochem. 213:1993;1117-1124.
46. Vega R.B., Kelly D.P. A role for estrogen-related receptor alpha in the control of mitochondrial fatty acid beta-oxidation during brown adipocyte differentiation. J. Biol. Chem. 272:1997;31693-31699.
47. Wu Z., Rosen E.D., Brun R. et al. Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell. 3:1999;151-158.
48. Yoshida T., Umekawa T. Beta 3 adrenergic receptor polymorphism and obesity. Nippon Rinsho. 56:1998;1871-1875.